Lu177-PSMA therapy is also known as Prostate-Specific Membrane Antigen Therapy. The treatment is a successful way to reduce the tumor's size and also stop them from multiplying. It is a popular treatment choice for men with advanced prostate cancer.
PSMA is a type of protein shown on the membrane of prostate cells. Lutetium is a radiation-based treatment that utilizes a molecule to attach itself to the PSMA receptors located on the cancer cells. Lu-177 emits beta radiation to damage cancer cells. The Lutetium molecule binds with the PSMA by targeting the molecules of PSMA, and the treatment becomes very precise.
The Lu-177 PSMA is administered intravenously through a catheter. Once it enters the body, it travels throughout the bloodstream to find the area with active prostate cancer growth and gets attached to the PSMA receptor. After that, it delivers the radiation directly into the nucleus of those cells. The radiation used in Lu-177 is designed only to destroy cancer cells, and the whole body is never exposed to the radiation.
Plan Travel to Treatment : Under One Roof
Transparent - Professional - Without Hassles
Send your reports and preferences to us
Receive quotation(s) within 48 Hours
Get received by us at destination
Get treated and fly back
Our Services for Lu177 Psma Therapy in Thailand
Transparent - Professional - Without Hassles
Book Doctor Appointment
Consult on Video or in-person at Hospital
Compare Cost Estimates
Hospitalisation Support
The success rate varies between 64% to 75%.
It is recommended to have three treatments, but a single treatment may be enough.